Lucia Merolle, Barbara Iotti, Pamela Berni, Elisa Bedeschi, Katya Boito, Eleonora Maurizi, Gaia Gavioli, Agnese Razzoli, Roberto Baricchi, Chiara Marraccini, Davide Schiroli
Various ocular surface diseases are treated with blood-derived eye drops. Their use has been introduced in clinical practice because of their metabolite and growth factor content, which promotes eye surface regeneration. Blood-based eye drops can be prepared from different sources (i.e., whole blood or platelet apheresis donation), as well as with different protocols (e.g., different dilutions and freeze/thaw cycles). This variability hampers the standardization of clinical protocols and, consequently, the evaluation of their clinical efficacy...
August 2, 2022: Journal of Visualized Experiments: JoVE